SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-101640
Filing Date
2020-09-02
Accepted
2020-09-02 08:04:30
Documents
14
Period of Report
2020-09-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2029742-1_8k.htm   iXBRL 8-K 28183
2 EXHIBIT 99.1 tm2029742d1_ex99-1.htm EX-99.1 13640
6 GRAPHIC tm2029742d1_ex99-1img01.jpg GRAPHIC 6505
  Complete submission text file 0001104659-20-101640.txt   232206

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnlo-20200902.xsd EX-101.SCH 3213
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnlo-20200902_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnlo-20200902_pre.xml EX-101.PRE 22728
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2029742-1_8k_htm.xml XML 3713
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 201155706
SIC: 2834 Pharmaceutical Preparations